Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Lack of dysferlin at this critical time may contribute to the pattern of muscle involvement that develops later, with the onset of a muscular dystrophy primarily affecting proximal or distal muscles.
|
10196375 |
1999 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
LVhMyoD transduced cells readily formed striated, multinucleate myotubes expressing a wide range of genes associated with muscular dystrophy (dystrophin, dysferlin, sarcoglycans, caveolin-3) and congenital myopathy (nebulin, actin, desmin, tropomyosin, troponin).
|
17303423 |
2007 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.
|
19380584 |
2009 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit.
|
30166241 |
2018 |
Muscular Dystrophy
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study.
|
14512171 |
2003 |
Muscular Dystrophy
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study.
|
14512171 |
2003 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
LHGDN |
Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.
|
16100712 |
2005 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.
|
16100712 |
2005 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in dysferlin gene cause several types of muscular dystrophy in humans, including the limb-girdle muscular dystrophy type 2B and the distal muscular dystrophy of Miyoshi.
|
16302276 |
2006 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in dysferlin cause a type of muscular dystrophy known as dysferlinopathy.
|
16608842 |
2006 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in dysferlin cause an inherited muscular dystrophy because of defective membrane repair.
|
21412170 |
2011 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in dysferlin, the first protein linked with the cell membrane repair mechanism, causes a group of muscular dystrophies called dysferlinopathies.
|
24438169 |
2014 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the dysferlin gene cause two autosomal recessive forms of muscular dystrophy: Miyoshi myopathy and limb-girdle muscular dystrophy type 2B.
|
16023782 |
2006 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the dysferlin (DYSF) gene cause 3 different phenotypes of muscular dystrophies: Miyoshi myopathy, limb-girdle muscular dystrophy type 2B, and distal anterior compartment myopathy.
|
16087766 |
2005 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the dysferlin gene are involved in two autosomal recessive muscular dystrophies: Miyoshi myopathy and limb-girdle muscular dystrophy type 2B.
|
24028392 |
2013 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the dysferlin gene are linked to a group of muscular dystrophies known as dysferlinopathies.
|
27349407 |
2016 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the DYSF gene cause clinically distinct forms of muscular dystrophies.
|
31218594 |
2019 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the skeletal muscle gene dysferlin cause two autosomal recessive forms of muscular dystrophy: Miyoshi myopathy (MM) and limb girdle muscular dystrophy type 2B (LGMD2B).
|
11468312 |
2001 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
New aspects on patients affected by dysferlin deficient muscular dystrophy.
|
19528035 |
2010 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
|
16705711 |
2006 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Our findings indicate that muscle membrane disruption and myofiber degeneration in dysferlinopathy were directly mediated by the loss of dysferlin via a new pathogenic mechanism in muscular dystrophies.
|
15254015 |
2004 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
MGD |
Our findings indicate that muscle membrane disruption and myofiber degeneration in dysferlinopathy were directly mediated by the loss of dysferlin via a new pathogenic mechanism in muscular dystrophies.
|
15254015 |
2004 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Proteasome inhibitors increase missense mutated dysferlin in patients with muscular dystrophy.
|
25143362 |
2014 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Recently, it was reported that a mutation in the dysferlin gene and/or dysferlin deficiency causes proximal and distal forms of muscular dystrophy, which are known by the term dysferlinopathy.
|
20667157 |
2010 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Recessive loss-of-function mutations in dysferlin lead to muscular dystrophies, for which no treatment is currently available.
|
22736764 |
2012 |